Counterpoint Mutual Funds LLC Has $393,000 Stock Position in Itron, Inc. (NASDAQ:ITRI)

Counterpoint Mutual Funds LLC boosted its stake in shares of Itron, Inc. (NASDAQ:ITRI) by 37.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,621 shares of the scientific and technical instruments company’s stock after buying an additional 989 shares during the period. Counterpoint Mutual Funds LLC’s holdings in Itron were worth $393,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Louisiana State Employees Retirement System raised its holdings in shares of Itron by 0.5% in the fourth quarter. Louisiana State Employees Retirement System now owns 21,800 shares of the scientific and technical instruments company’s stock valued at $2,367,000 after purchasing an additional 100 shares during the last quarter. Quarry LP raised its holdings in shares of Itron by 29.0% in the third quarter. Quarry LP now owns 454 shares of the scientific and technical instruments company’s stock valued at $48,000 after purchasing an additional 102 shares during the last quarter. Continuum Advisory LLC raised its holdings in shares of Itron by 42.1% in the third quarter. Continuum Advisory LLC now owns 344 shares of the scientific and technical instruments company’s stock valued at $40,000 after purchasing an additional 102 shares during the last quarter. Stifel Financial Corp raised its holdings in shares of Itron by 2.2% in the third quarter. Stifel Financial Corp now owns 4,921 shares of the scientific and technical instruments company’s stock valued at $526,000 after purchasing an additional 108 shares during the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC raised its holdings in shares of Itron by 6.1% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,185 shares of the scientific and technical instruments company’s stock valued at $237,000 after purchasing an additional 125 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Christopher E. Ware sold 648 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $92.90, for a total value of $60,199.20. Following the completion of the sale, the senior vice president now owns 20,326 shares of the company’s stock, valued at approximately $1,888,285.40. The trade was a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Mary C. Hemmingsen sold 750 shares of the business’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $107.27, for a total transaction of $80,452.50. Following the completion of the sale, the director now directly owns 5,630 shares of the company’s stock, valued at approximately $603,930.10. The trade was a 11.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,037 shares of company stock valued at $385,815 over the last ninety days. 1.45% of the stock is currently owned by company insiders.

Itron Trading Up 1.9 %

ITRI stock opened at $106.55 on Tuesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.36 and a quick ratio of 2.83. The company has a fifty day moving average price of $104.01 and a two-hundred day moving average price of $107.51. Itron, Inc. has a one year low of $86.45 and a one year high of $124.90. The stock has a market cap of $4.81 billion, a price-to-earnings ratio of 21.83, a price-to-earnings-growth ratio of 0.81 and a beta of 1.49.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ITRI. Piper Sandler lifted their price objective on shares of Itron from $119.00 to $124.00 and gave the company a “neutral” rating in a report on Thursday, February 27th. Guggenheim lowered their target price on shares of Itron from $135.00 to $133.00 and set a “buy” rating on the stock in a report on Thursday, February 27th. Oppenheimer boosted their target price on shares of Itron from $124.00 to $131.00 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. StockNews.com downgraded shares of Itron from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 1st. Finally, Canaccord Genuity Group boosted their target price on shares of Itron from $130.00 to $132.00 and gave the stock a “buy” rating in a report on Wednesday, February 26th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $127.64.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.